MK-7246 |
Antagonist of PTGDR2
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| PTGDR2 |
|
|
Antagonist
100 nM, up to 1 uM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
> 100-fold against related receptors; Hits in the GPCR scan are SLC6A3 (Ki = 283 nM), GABA/PBR (Ki = ...
Potency Cellular
In Vitro
PTGDR2
Mode of Action: Antagonist
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1016/j.bmcl.2010.11.015
In Vivo Validations
Rat
Dose: 5 mg/Kg PO, 1 mg/Kg IV
Route of delivery:
Oral, Intravenus
Plasma half life:
5.6 h
Systemic clearance:
2.2 mL/min/kg
Cmax:
12200 nM
Area Under the Curve::
128 mM*h
Bioavailability:
138 %
Volume of Distribution at Steady-State:
0.98 L/Kg
DOI Reference: 10.1016/j.bmcl.2010.11.015
Dog
Dose: 5 mg/Kg PO, 1 mg/Kg IV
Route of delivery:
Oral, Intravenus
Plasma half life:
8.4 h
Systemic clearance:
15 mL/min/kg
Cmax:
580 nM
Area Under the Curve::
1.6 mM*h
Bioavailability:
67 %
Volume of Distribution at Steady-State:
2.3 L/Kg
DOI Reference: 10.1016/j.bmcl.2010.11.015
Negative Control Compounds
Chemical Information
| Molecular Formula | C21H21FN2O4S |
| SMILEs | CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1 |
| InChI | InChI=1S/C21H21FN2O4S/c1-23(29(27,28)16-9-6-14(22)7-10-16)15-8-11-20-18(12-21(25)26)17-4-2-3-5-19(17)24(20)13-15/h2-7,9-10,15H,8,11-13H2,1H3,(H,25,26)/t15-/m1/s1 |
| Molecular weight | 416.12 Da |
| AlogP | 3.043000000000002 |
| HBond acceptors | 6 |
| HBond donors | 1 |
| Atoms | 50 |
| PAINS * | Yes |
* This is an automated alert only, and may not necessarily indicate an issue with this probe. ( Learn more about PAINS )
References
Publications
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.